MVP - MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED

[nipper]

and it has been downhill for the last few years.... $5.00 at start of 2022 down to $1.40 in June and a bit of a retrace to $2.40 recently.... and now a Trading Halt and Cap Raise.

Still running with Penthrox (Green Whistle) and Repiratory (Asthma).
Sales increasing, still EBIT negative.

Raising $30 million at $2.00 a share
• A fully underwritten capital raising of approximately $30 million comprising:
• An institutional placement of New Shares to eligible investors to raise approximately $15.0 million
• A 1 for 9.5 pro rata accelerated non renounceable entitlement issue for approx $15 million

Going towards

• Operating activities, including growth in Europe and Australia and enhanced organisational capability
• Capex operations

[nipper]